Department of Intensive Care Unit, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei Province, China; Institute of Biomedical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei Province, China.
Department of Intensive Care Unit, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei Province, China.
Microb Pathog. 2019 Jun;131:106-111. doi: 10.1016/j.micpath.2019.03.039. Epub 2019 Mar 30.
Sepsis is characterized by life-threatening organ dysfunction caused by a deregulated host response to infection. Autophagy is one of the innate immune defense mechanisms against microbial attack. Previous studies have demonstrated that autophagy is activated initially in sepsis, followed by a subsequent phase of impairment. A number of sepsis-related studies have shown that autophagy plays a protective role in multiple organ injuries partly by clearing pathogens, regulating inflammation and metabolism, inhibiting apoptosis and suppressing immune reactions. In this review, we present a general overview of and recent advances in the role of autophagy in sepsis and consider the therapeutic potential of autophagy activators in treating sepsis.
脓毒症的特征是感染导致宿主反应失调而引起危及生命的器官功能障碍。自噬是机体固有免疫防御机制之一,抵御微生物攻击。既往研究显示,脓毒症早期自噬被激活,随后发生自噬损伤。许多脓毒症相关研究表明,自噬在清除病原体、调节炎症和代谢、抑制细胞凋亡和抑制免疫反应等方面发挥保护作用,从而减轻多器官损伤。本综述概述了自噬在脓毒症中的作用及研究进展,并探讨了自噬激活剂治疗脓毒症的潜在治疗作用。